Egill Rostrup Selected Research

Egill Rostrup Research Topics

Disease

27	Schizophrenia (Dementia Praecox) 01/2024 - 05/2012
17	Psychotic Disorders (Schizoaffective Disorder) 03/2024 - 01/2014
5	Cognitive Dysfunction 12/2022 - 09/2014
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2012
3	Migraine Disorders (Migraine) 10/2018 - 04/2009
2	Body Weight (Weight, Body) 01/2022 - 02/2016
2	Stroke (Strokes) 01/2022 - 01/2020
2	Substance-Related Disorders (Drug Abuse) 02/2021 - 01/2019
2	Hyperventilation 01/2020 - 12/2019
2	Epilepsy (Aura) 10/2018 - 01/2016
2	Headache (Headaches) 10/2018 - 04/2009
2	Weight Gain 02/2016 - 08/2012
2	Weight Loss (Weight Reduction) 01/2014 - 08/2012
1	Hallucinations (Hallucination) 01/2024
1	Delirium 01/2021
1	Aphasia (Dysphasia) 01/2020
1	Cerebral Small Vessel Diseases 01/2020
1	Lacunar Stroke 06/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Brain Injuries (Brain Injury) 01/2019
1	Fatigue 01/2019
1	Parkinson Disease (Parkinson's Disease) 12/2018
1	Sleep Deprivation 12/2018
1	Disease Progression 10/2018
1	Migraine with Aura (Familial Hemiplegic Migraine) 10/2018
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 03/2016
1	Mental Disorders (Mental Disorder) 10/2015
1	Obesity 01/2014
1	Dyslipidemias (Dyslipidemia) 01/2014
1	Hyperoxia 09/2013
1	Overweight 08/2012
1	Hypercapnia 04/2009
1	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2008
1	Synovitis 04/2004

Drug/Important Bio-Agent (IBA)

32	Antipsychotic Agents (Antipsychotics)IBA 01/2024 - 05/2012
11	Dopamine (Intropin)FDA LinkGeneric 01/2024 - 12/2012
10	Glutamic Acid (Glutamate)FDA Link 03/2024 - 01/2018
7	gamma-Aminobutyric Acid (GABA)IBA 12/2023 - 01/2020
6	Biomarkers (Surrogate Marker)IBA 12/2019 - 02/2008
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 08/2012
2	Glutamine (L-Glutamine)FDA Link 07/2023 - 01/2020
2	Aripiprazole (Abilify)FDA Link 02/2023 - 01/2023
2	Tadalafil (Cialis)FDA Link 12/2022 - 01/2020
2	Exenatide (Byetta)FDA Link 01/2022 - 01/2014
2	Phosphodiesterase 5 InhibitorsIBA 01/2020 - 04/2009
2	Acetazolamide (Diamox)FDA LinkGeneric 01/2020 - 12/2019
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2020 - 09/2015
2	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2020 - 04/2009
2	Amisulpride (Solian)IBA 01/2019 - 02/2016
2	Sildenafil Citrate (Viagra)FDA Link 01/2017 - 04/2009
1	BenzodiazepinesIBA 12/2023
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Antidepressive Agents (Antidepressants)IBA 11/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2020
1	Oxidopamine (6 Hydroxydopamine)IBA 12/2018
1	Cilostazol (Pletal)FDA LinkGeneric 10/2018
1	Ketamine FDA LinkGeneric 01/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018
1	EsketamineIBA 01/2018
1	DystrophinIBA 01/2017
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Dopamine D2 Receptor AntagonistsIBA 02/2016
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2016
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2016
1	LigandsIBA 01/2016
1	epideprideIBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 09/2014
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2014
1	Troleandomycin (TAO)FDA Link 01/2014
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2014
1	HomocysteineIBA 01/2014
1	Oxygen (Dioxygen)IBA 09/2013
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 08/2012
1	Hormones (Hormone)IBA 08/2012
1	C-Reactive ProteinIBA 04/2004

Therapy/Procedure

1	Electrodes (Electrode) 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Secondary Prevention 06/2019
1	Aftercare (After-Treatment) 02/2016
1	Subcutaneous Injections 01/2014